Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders

A technology for mental disorders and cognitive disorders, applied in the field of practical medicine, to solve problems such as no cure, cure AD or prevent loss

Pending Publication Date: 2022-02-18
LA PHARMA TECH INC
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, acetylcholinesterase inhibitors such as donepezil, rivastigmine and galantamine will not cure AD or prevent the loss of these abilities at some point in the future
Therefore, there is currently no cure for AD and the inventors' efforts are to find better ways to reverse the disease, delay and prevent its progression

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Diagnosed with advanced Alzheimer's disease, MMSE score 10-1 and NPI-Q severity with a once-daily tablet form of a pharmaceutical composition comprising 12 mg azelastine HCl and 3 mg donepezil HCl Ten patients with a score of 3 and a pain score of 4 or 5. After 12 weeks, these 10 patients would have increased their MMSE scores by at least 9 points into the 20-10 point range, a 1- to 9-fold improvement in MMSE scores, and their NPI-Q would have had a severity score of 1 and a severity score of 1. Or a pain score of 2 points, an improvement of 2.5x to 4x.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A pharmaceutical composition containing the therapeutically active ingredients of azelastine or a pharmaceutically acceptable salt of azelastine and donepezil or rivastigmine or galantamine or a pharmaceutically acceptable salt of thereof is disclosed. A method of using the pharmaceutical composition for treating patients suffering from mental, behavioral, cognitive disorders is also disclosed.

Description

technical field [0001] The present invention relates to the field of applied medicine, i.e. to displaying neurotropic action, alleviating clinical manifestations of mental disorders, behavioral disorders, cognitive disorders in the case of organic damage of various origins to the central nervous system combination of pharmaceutical compositions. Background technique [0002] Alzheimer's disease (AD) is a progressive, chronic neurodegenerative disease that usually begins slowly and progressively worsens over time. Among older adults, Alzheimer's disease is the most common cause of dementia. Dementia is the loss of cognitive function (thinking, memory, and reasoning) and behavioral abilities to the extent that it interferes with a person's daily life and activities. In its early stages, memory loss is mild, but in advanced AD, individuals lose the ability to carry on conversations and respond to their environment. If left untreated, AD eventually leads to death. Typical li...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): H01M10/04H01M10/26H01M4/00
CPCA61K31/55A61K31/445A61K31/27A61P25/28Y02P70/50A61K2300/00
Inventor 王建民崔歌平
Owner LA PHARMA TECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products